Radiotherapy with and without temozolomide in elderly patients with glioblastoma

Strahlentherapie und Onkologie

Volumn 188, Issue 2, 2012, Pages 154-159

  Niyazi, M ^a   Schwarz, S B ^a   Suchorska, B ^a   Belka, C ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Elderly; Glioblastoma; Radiotherapy; Temozolomide; Treatment outcome

Indexed keywords

GADOLINIUM; TEMOZOLOMIDE; ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE;

AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GERIATRIC PATIENT; GLIOBLASTOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; BRAIN TUMOR; CHEMORADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; GERMANY; MORTALITY; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; DACARBAZINE; FEMALE; GERMANY; GLIOBLASTOMA; HUMANS; MALE; PREVALENCE; PROGNOSIS; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84858055691     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-0026-7     Document Type: Article

References (33)

1. Fleury A, Menegoz F, Grosclaude P et al (1997) Descriptive epidemiology of cerebral gliomas in France. Cancer 79:1195-1202
2. Chakrabarti I, Cockburn M, Cozen W et al (2005) A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999. Cancer 104:2798-2806
3. Curran WJ Jr, Scott CB, Horton J et al (1993) Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85:704-710
4. Meckling S, Dold O, Forsyth PA et al (1996) Malignant supratentorial glioma in the elderly: is radiotherapy useful? Neurology 47:901-905
5. Brandes AA, Compostella A, Blatt V, Tosoni A (2006) Glioblastoma in the elderly: current and future trends. Crit Rev Oncol Hematol 60:256-266
6. Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459-466
7. Stupp R, Mason WP, Bent MJ van den et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
8. Leitzen C, Schild HH, Bungart B et al (2011) Prediction of clinical course of glioblastomas by MRI during radiotherapy. Strahlenther Onkol 186:681-686
9. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280
10. Kopecky J, Priester P, Slovacek L et al (2010) Aplastic anemia as a cause of death in a patient with glioblastoma multiforme treated with temozolomide. Strahlenther Onkol 186:452-456
11. Fels F, Kraft JW, Grabenbauer GG (2010) Geriatrics and radiation oncology. part 1: how to identify high-risk patients and basic treatment principles. Strahlenther Onkol 186:411-422
12. Marijnen CAM, Berg SMP van den, Duinen SG van et al (2005) Radiotherapy is effective in patients with glioblastoma multiforme with a limited prognosis and in patients above 70 years of age: a retrospective single institution analysis. Radiother Oncol 75:210-216
13. Brandes AA, Vastola F, Basso U et al (2003) A prospective study on glioblastoma in the elderly. Cancer 97:657-662
14. Armstrong TS, Gilbert MR (1996) Glial neoplasms: classification, treatment, and pathways for the future. Oncol Nurs Forum 23:615-625 (quiz 26-27)
15. Pierga JY, Hoang-Xuan K, Feuvret L et al (1999) Treatment of malignant gliomas in the elderly. J Neurooncol 43:187-193
16. Piccirilli M, Bistazzoni S, Gagliardi FM et al (2006) Treatment of glioblastoma multiforme in elderly patients. Clinico-therapeutic remarks in 22 patients older than 80 years. Tumori 92:98-103
17. Iwamoto FM, Cooper AR, Reiner AS et al (2009) Glioblastoma in the elderly The Memorial Sloan- Kettering Cancer Center experience (1997-2007). Cancer 115:3758-3766
18. Kimple RJ, Grabowski S, Papez M et al (2010) Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme? Am J Clin Oncol 33:265-270
19. Minniti G, De Sanctis V, Muni R et al (2009) Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma. J Neurooncol 91:95-100
20. Gerstein J, Franz K, Eberlein K, Rodel C (2010) Radiotherapy with concomitant temozolomide in elderly patients with glioblastoma multiforme. Onkologie 33:56
21. Fiorica F, Berretta M, Colosimo C et al (2009) Glioblastoma in elderly patients: safety and efficacy of adjuvant radiotherapy with concomitant temozolomide. Arch Gerontol Geriatr 51:31-35
22. Roa W, Brasher PM, Bauman G et al (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22:1583-1588
23. Mohan DS, Suh JH, Phan JL et al (1998) Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 42:981-987
24. Villa S, Vinolas N, Verger E et al (1998) Efficacy of radiotherapy for malignant gliomas in elderly patients. Int J Radiat Oncol Biol Phys 42:977-980
25. Glantz M, Chamberlain M, Liu Q et al (2003) Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer 97:2262-2266
26. Chinot OL, Barrie M, Frauger E et al (2004) Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 100:2208-2214
27. Chamberlain MC, Chalmers L (2007) A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma. J Neurooncol 82:207-209
28. Gerstein J, Franz K, Steinbach JP et al (2010) Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma. Radiother Oncol 97:382-386
29. Gerstein J, Franz K, Steinbach J et al (2010) Combined radiochemotherapy with temozolomide in patients ≥ 65 years with multiform glioblastoma: clinical outcomes and prognostic factors. Strahlenther Onkol 186 (Sondernr 1):30
30. Brandes AA, Franceschi E, Tosoni A et al (2009) Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer 115:3512-3518
31. Minniti G, De Sanctis V, Muni R et al (2008) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol 88:97-103
32. Combs SE, Wagner J, Bischof M et al (2008) Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int J Radiat Oncol Biol Phys 70:987-992
33. Grabenbauer GG (2010) Long-term survival of patients with glioblastoma multiforme treated with chemoradiation: correlation with MGMT promoter methylation status. Strahlenther Onkol 186:185-187